| Biotechnology Industry | Healthcare Sector | Ms. Isabel Lozano Fernandez CEO | XDUS Exchange | ES0105148003 ISIN |
| Spain Country | 2,084 Employees | - Last Dividend | 17 Sep 2020 Last Split | - IPO Date |
Atrys Health, S.A., is a pioneering biomedical company based in Madrid, Spain, renowned for offering a broad spectrum of diagnostic services and innovative medical treatments. Established in 2007, the company initiated its operations under the name Althia Health, S.L., witnessing a significant rebranding in May 2016 to Atrys Health, S.A. Focused on integrating advanced technology in the healthcare sector, Atrys Health leverages telemedicine to enhance the accessibility and efficiency of healthcare services, spanning across various medical specialties including radiology, cardiology, ophthalmology, and dermatology. Atrys Health is committed to advancing medical research and clinical practices by developing new therapeutic modalities and diagnostic tools, thereby contributing to the improvement of global healthcare standards.
Atrys Health specializes in a comprehensive range of diagnostic services aimed at facilitating early and precise disease detection. The company covers essential areas such as pathology, hematology, molecular pathology, and genetics, employing advanced methodologies to ensure accuracy and reliability.
Recognizing the critical need for accuracy in diagnostics, Atrys Health offers diagnostic second opinion services. This initiative provides patients and healthcare professionals with an additional layer of analysis and verification for initial diagnostic findings, ensuring a higher degree of certainty in treatment planning.
To support comprehensive diagnostic evaluations, Atrys Health maintains an extensive test directory. This resource enables healthcare practitioners to access a wide array of tests, facilitating informed decision-making in patient care and treatment management.
At the forefront of clinical innovation, Atrys Health actively engages in clinical trials and research & development projects. These endeavors aim to explore and validate novel therapeutic approaches and diagnostic tools, contributing to the advancement of medical science and patient care.
Atrys Health integrates telemedicine to offer expert medical consultations and services across several specialties, including radiology, cardiology, ophthalmology, and dermatology. This approach enables patients to receive high-quality care remotely, improving accessibility and convenience.
As part of its comprehensive treatment offerings, Atrys Health provides advanced radiotherapy services. This involves the use of high-energy radiation to treat cancer and other medical conditions, highlighting the company’s contribution to oncology.
Atrys Health is dedicated to the development of new therapeutic modalities and diagnostic tools. Through innovative research and technological advancement, the company strives to enhance the efficacy and accuracy of medical treatments and diagnostics, paving the way for future healthcare innovations.